Christian Elling

Christian E. Elling heads the early-stage biotech investment unit Lundbeckfonden BioCapital.

He is a member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics, SNIPR Biome, Folium and a former member of the board of directors of EpiTherapeutics and Inagen.

Christian was previously co-founder, Vice President of Biology and Development, and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his Ph.D. in pharmacology from the University of Copenhagen, Denmark.